AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

IRWD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.10%

Insider Buying (Last 12 Months): $460,538.96

Insider Selling (Last 12 Months): $4,670,196.08

Ironwood Pharmaceuticals Insider Trading History Chart

Ironwood Pharmaceuticals Share Price & Price History

^$8.28

▲ +0.06 (0.73%)

As of 05/2/2024 01:51 PM ET

Days: 30 | 90 | 365

Biden to Launch “FedNOW” [Move Your Money Now]

From Priority Gold | Ad

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

Ironwood Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2024	Jon R Duane	Director	Buy	6,920	$8.70	$60,204.00	121,028
3/4/2024	Sravan Kumar Emany	CFO	Buy	10,684	$9.38	$100,215.92	301,733
2/12/2024	Andrew Davis	SVP	Sell	9,846	$15.24	$150,053.04	208,324
2/12/2024	Michael Shetzline	CMO	Sell	38,618	$15.24	$588,538.32	340,484
2/12/2024	Minardo John	Insider	Sell	47,380	$15.24	$722,071.20	224,796
2/12/2024	Thomas A. McCourt	CEO	Sell	177,164	$15.24	$2,699,979.36	832,774
9/15/2023	Sravan Kumar Emany	CFO	Buy	36,072	$8.32	$300,119.04	188,730
5/30/2023	Thomas A. McCourt	CEO	Sell	26,632	$10.70	$284,962.40	758,284
5/8/2023	Thomas A. McCourt	CEO	Sell	21,148	$10.62	$224,591.76	820,916
3/27/2023	Thomas A. McCourt	CEO	Sell	46,129	$10.67	$492,196.43	842,064
3/3/2023	Thomas A. McCourt	CEO	Sell	33,756	$11.22	$378,742.32	647,598
2/27/2023	Andrew Davis	SVP	Sell	1,751	$11.41	$19,978.91	153,218
2/27/2023	Jason Rickard	COO	Sell	16,746	$11.41	$191,071.86	350,077
2/27/2023	Michael Shetzline	CMO	Sell	9,468	$11.41	$108,029.88	271,440
2/27/2023	Ronald Silver	Insider	Sell	2,929	$11.41	$33,419.89	101,540
2/27/2023	Thomas A. McCourt	CEO	Sell	30,004	$11.41	$342,345.64	712,581
1/5/2023	Thomas A. McCourt	CEO	Sell	110,962	$12.07	$1,339,311.34	712,440
10/3/2022	Thomas A. McCourt	CEO	Sell	18,899	$10.41	$196,738.59	712,440
8/11/2022	Mark G. Currie	Director	Sell	70,000	$11.78	$824,600.00	521,758
8/9/2022	Jason Rickard	COO	Sell	18,041	$11.75	$211,981.75	376,730
8/1/2022	Thomas A. McCourt	CEO	Sell	23,229	$11.35	$263,649.15	757,785
6/30/2022	Thomas A. McCourt	CEO	Sell	19,959	$11.58	$231,125.22	778,922
6/14/2022	Marla L Kessler	Director	Sell	7,610	$11.65	$88,656.50	84,148
6/7/2022	Mark G. Currie	Director	Sell	190,383	$12.01	$2,286,499.83	591,758
5/23/2022	Thomas A. McCourt	CEO	Sell	36,308	$11.50	$417,542.00	798,881
3/24/2022	Ronald Silver	Insider	Sell	3,031	$12.75	$38,645.25
12/22/2021	Thomas A. McCourt	CEO	Sell	46,327	$11.41	$528,591.07
12/16/2021	Jason Rickard	COO	Sell	27,000	$11.28	$304,560.00
12/14/2021	Julie McHugh	Director	Sell	10,000	$11.02	$110,200.00
11/23/2021	Jason Rickard	COO	Sell	17,193	$11.58	$199,094.94
11/23/2021	Michael Shetzline	CMO	Sell	13,776	$11.58	$159,526.08
11/23/2021	Ronald Silver	Insider	Sell	1,462	$11.58	$16,929.96
11/23/2021	Thomas A. McCourt	CEO	Sell	52,644	$11.58	$609,617.52
6/14/2021	Mark G. Currie	Director	Sell	23,571	$11.59	$273,187.89	570,187
5/24/2021	Jason Rickard	COO	Sell	516	$12.25	$6,321.00	362,538
5/24/2021	Michael Shetzline	CMO	Sell	2,077	$12.25	$25,443.25	197,437
5/24/2021	Thomas A. McCourt	CEO	Sell	1,716	$12.25	$21,021.00	566,499

Biden to Launch “FedNOW” [Move Your Money Now]

From Priority Gold | Ad

Get your free information kit NOW, before it's too late.

SEC Filings (Institutional Ownership Changes) for Ironwood Pharmaceuticals (NASDAQ:IRWD)

Institutional Buying and Selling by Quarter

Ironwood Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/2/2024	Daiwa Securities Group Inc.	50,870	$0.44M	0.0%	+1,957.0%	0.032%
5/2/2024	Tokio Marine Asset Management Co. Ltd.	18,800	$0.16M	0.0%	+46.9%	0.012%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	94,683	$0.83M	0.0%	+5.0%	0.060%
4/29/2024	Principal Financial Group Inc.	804,900	$7.01M	0.0%	+0.4%	0.514%
4/29/2024	China Universal Asset Management Co. Ltd.	30,091	$0.26M	0.0%	+66.6%	0.019%
4/26/2024	Prairiewood Capital LLC	39,306	$0.34M	0.2%	-4.3%	0.025%
4/26/2024	Yousif Capital Management LLC	50,649	$0.44M	0.0%	-10.2%	0.032%
4/25/2024	New York State Teachers Retirement System	52,420	$0.46M	0.0%	+36.2%	0.033%
4/22/2024	Intrinsic Value Partners LLC	47,745	$0.42M	0.4%	-3.5%	0.031%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	55,867	$0.49M	0.0%	N/A	0.036%
4/18/2024	Allspring Global Investments Holdings LLC	79,361	$0.69M	0.0%	+63.2%	0.051%
4/17/2024	Grimes & Company Inc.	37,759	$0.33M	0.0%	-3.5%	0.024%
4/16/2024	Hodges Capital Management Inc.	863,500	$7.52M	0.5%	N/A	0.552%
4/5/2024	Los Angeles Capital Management LLC	85,343	$0.74M	0.0%	+209.9%	0.055%
3/22/2024	PNC Financial Services Group Inc.	4,383	$50K	0.0%	+152.2%	0.003%
3/11/2024	Vanguard Group Inc.	16,033,545	$183.42M	0.0%	+7.6%	10.243%
3/5/2024	Gerber LLC	27,600	$0.32M	0.3%	N/A	0.018%
2/20/2024	Eventide Asset Management LLC	740,554	$8.47M	0.1%	N/A	0.474%
2/15/2024	Parkman Healthcare Partners LLC	120,652	$1.38M	0.2%	+20.7%	0.077%
2/15/2024	Brown Capital Management LLC	3,709,431	$42.44M	0.6%	-0.3%	2.376%
2/14/2024	Redwood Investment Management LLC	282,619	$3.23M	0.3%	-14.3%	0.181%
2/14/2024	Hotchkis & Wiley Capital Management LLC	1,140,470	$13.05M	0.0%	+4.0%	0.730%
2/14/2024	13D Management LLC	367,649	$4.21M	2.5%	+971.8%	0.235%
2/14/2024	Old West Investment Management LLC	56,921	$0.65M	0.3%	+1.4%	0.036%
2/13/2024	Quantedge Capital Pte Ltd	17,400	$0.20M	0.1%	-90.3%	0.011%
2/13/2024	Tower Research Capital LLC TRC	5,382	$62K	0.0%	-78.8%	0.003%
2/13/2024	Armistice Capital LLC	5,700,000	$65.21M	0.9%	+64.9%	3.651%
2/13/2024	Rafferty Asset Management LLC	701,770	$8.03M	0.0%	-19.7%	0.449%
2/9/2024	Aigen Investment Management LP	21,270	$0.24M	0.0%	+58.3%	0.014%
2/9/2024	Hillsdale Investment Management Inc.	157,400	$1.80M	0.1%	N/A	0.101%
2/9/2024	Norges Bank	814,774	$9.32M	0.0%	N/A	0.522%
2/8/2024	First Eagle Investment Management LLC	907,225	$10.38M	0.0%	+11.1%	0.581%
2/8/2024	Quadrant Capital Group LLC	8,578	$98K	0.0%	+68.8%	0.005%
2/8/2024	Moran Wealth Management LLC	200,160	$2.29M	0.1%	-1.1%	0.128%
2/8/2024	Massachusetts Financial Services Co. MA	98,677	$1.13M	0.0%	N/A	0.063%
2/7/2024	Dimensional Fund Advisors LP	3,081,811	$35.26M	0.0%	-44.1%	1.974%
2/7/2024	QRG Capital Management Inc.	258,971	$2.96M	0.0%	-3.7%	0.166%
2/7/2024	Jump Financial LLC	33,963	$0.39M	0.0%	N/A	0.022%
2/7/2024	BNP Paribas Financial Markets	572,947	$6.56M	0.0%	+35.0%	0.367%
2/7/2024	Teacher Retirement System of Texas	32,469	$0.37M	0.0%	-18.1%	0.021%
2/7/2024	Intrinsic Value Partners LLC	49,455	$0.57M	0.7%	-1.8%	0.032%
2/7/2024	E Fund Management Co. Ltd.	37,687	$0.43M	0.0%	-16.1%	0.024%
2/6/2024	Charles Schwab Investment Management Inc.	1,288,653	$14.74M	0.0%	+4.7%	0.825%
2/6/2024	LSV Asset Management	6,782,101	$77.59M	0.2%	-5.3%	4.344%
2/6/2024	Amalgamated Bank	53,769	$0.62M	0.0%	-6.7%	0.034%
2/6/2024	Los Angeles Capital Management LLC	27,537	$0.32M	0.0%	-45.5%	0.018%
2/6/2024	Swiss National Bank	276,700	$3.17M	0.0%	-10.0%	0.177%
2/5/2024	Victory Capital Management Inc.	4,224,583	$48.33M	0.1%	-4.1%	2.706%
2/5/2024	SummerHaven Investment Management LLC	68,745	$0.79M	0.5%	+1.4%	0.044%
2/5/2024	Russell Investments Group Ltd.	225,620	$2.58M	0.0%	+39.9%	0.145%
2/2/2024	State of New Jersey Common Pension Fund D	258,524	$2.96M	0.0%	-5.4%	0.166%
2/1/2024	New York State Common Retirement Fund	791,736	$9.06M	0.0%	+1.1%	0.507%
2/1/2024	Duality Advisers LP	64,842	$0.74M	0.1%	-12.1%	0.042%
2/1/2024	Hussman Strategic Advisors Inc.	63,000	$0.72M	0.2%	-49.2%	0.040%
2/1/2024	Handelsbanken Fonder AB	47,855	$0.55M	0.0%	+65.3%	0.031%
2/1/2024	Signaturefd LLC	2,160	$25K	0.0%	+61.4%	0.001%
1/31/2024	Xponance Inc.	14,156	$0.16M	0.0%	-5.1%	0.009%
1/31/2024	Daiwa Securities Group Inc.	2,473	$29K	0.0%	+331.6%	0.002%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	32,721	$0.37M	0.0%	+19.4%	0.021%
1/30/2024	Mackenzie Financial Corp	10,460	$0.12M	0.0%	-17.7%	0.007%
1/29/2024	Louisiana State Employees Retirement System	68,700	$0.79M	0.0%	N/A	0.044%
1/26/2024	GW Henssler & Associates Ltd.	13,821	$0.16M	0.0%	-28.5%	0.009%
1/25/2024	Allspring Global Investments Holdings LLC	48,616	$0.56M	0.0%	+645.1%	0.031%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	90,161	$1.03M	0.0%	-1.0%	0.058%
1/24/2024	Grimes & Company Inc.	39,140	$0.45M	0.0%	-2.3%	0.025%
1/24/2024	New York State Teachers Retirement System	38,500	$0.44M	0.0%	-26.6%	0.025%
1/24/2024	China Universal Asset Management Co. Ltd.	18,061	$0.21M	0.0%	+351.9%	0.012%
1/19/2024	State of Alaska Department of Revenue	84,525	$0.97M	0.0%	-1.1%	0.054%
1/16/2024	Raymond James Financial Services Advisors Inc.	15,330	$0.18M	0.0%	+10.7%	0.010%
1/5/2024	Exchange Traded Concepts LLC	227,767	$2.61M	0.1%	-3.4%	0.146%
12/19/2023	Public Employees Retirement System of Ohio	89,500	$0.86M	0.0%	N/A	0.057%
12/18/2023	Vanguard Group Inc.	14,895,700	$143.45M	0.0%	+0.3%	9.541%
11/30/2023	American Century Companies Inc.	1,281,269	$12.34M	0.0%	+7.5%	0.821%
11/21/2023	Walleye Capital LLC	166,968	$1.61M	0.0%	N/A	0.107%
11/17/2023	Jacobs Levy Equity Management Inc.	2,378,295	$22.90M	0.1%	N/A	1.524%
11/15/2023	Mercer Global Advisors Inc. ADV	244,749	$2.36M	0.0%	+16.5%	0.157%
11/15/2023	13D Management LLC	34,301	$0.33M	0.2%	-93.3%	0.022%
11/15/2023	Adage Capital Partners GP L.L.C.	2,462,300	$23.71M	0.1%	+160.9%	1.578%
11/15/2023	Alps Advisors Inc.	115,139	$1.11M	0.0%	-7.5%	0.074%
11/15/2023	Armistice Capital LLC	3,456,000	$33.28M	0.5%	N/A	2.215%
11/15/2023	AXQ Capital LP	20,000	$0.19M	0.1%	N/A	0.013%
11/15/2023	Alberta Investment Management Corp	210,731	$2.03M	0.0%	-7.4%	0.135%
11/15/2023	Glenmede Trust Co. NA	1,324,735	$12.76M	0.1%	+26.0%	0.849%
11/14/2023	Corton Capital Inc.	16,178	$0.16M	0.1%	N/A	0.010%
11/14/2023	MQS Management LLC	29,066	$0.28M	0.2%	N/A	0.019%
11/14/2023	O Shaughnessy Asset Management LLC	35,638	$0.34M	0.0%	-73.2%	0.023%
11/14/2023	Oak Associates Ltd. OH	61,384	$0.59M	0.0%	+18.3%	0.039%
11/14/2023	Profund Advisors LLC	151,279	$1.46M	0.1%	+10.4%	0.097%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	251,500	$2.42M	0.0%	-11.2%	0.161%
11/13/2023	Dark Forest Capital Management LP	24,195	$0.23M	0.0%	N/A	0.016%
11/13/2023	Brandywine Global Investment Management LLC	476,559	$4.59M	0.0%	-1.1%	0.305%
11/13/2023	Hsbc Holdings PLC	256,801	$2.47M	0.0%	+4.2%	0.165%
11/13/2023	Quantedge Capital Pte Ltd	179,900	$1.73M	0.9%	-61.1%	0.115%
11/13/2023	Aigen Investment Management LP	13,437	$0.13M	0.0%	N/A	0.009%
11/13/2023	Invesco Ltd.	1,044,721	$10.06M	0.0%	-37.3%	0.670%
11/13/2023	QRG Capital Management Inc.	268,822	$2.59M	0.0%	N/A	0.172%
11/13/2023	Rafferty Asset Management LLC	874,052	$8.42M	0.0%	+20.5%	0.560%
11/13/2023	Old West Investment Management LLC	56,160	$0.54M	0.3%	-27.8%	0.036%
11/13/2023	E Fund Management Co. Ltd.	44,896	$0.43M	0.0%	+15.2%	0.029%
11/9/2023	Rhumbline Advisers	458,236	$4.41M	0.0%	+0.9%	0.294%

Data available starting January 2016

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $8.28

$8.11

$8.33

50 Day Range

MA: $9.09

$7.60

$15.18

52 Week Range

Now: $8.28

$7.53

$15.70

Volume

379,499 shs

Average Volume

4,263,958 shs

Market Capitalization

$1.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of Ironwood Pharmaceuticals?: Ironwood Pharmaceuticals' top insider shareholders include:
Thomas A Mccourt (CEO)
Mark G Currie (Director)
Jason Rickard (COO)
Michael Shetzline (CMO)
Sravan Kumar Emany (CFO)
Minardo John (Insider)
Andrew Davis (SVP)
Jon R Duane (Director)
Ronald Silver (Insider)
Marla L Kessler (Director)
Learn More about top insider investors at Ironwood Pharmaceuticals.
Who are the major institutional investors of Ironwood Pharmaceuticals?: Ironwood Pharmaceuticals' top institutional investors include:
Hodges Capital Management Inc. — 0.55%
Principal Financial Group Inc. — 0.51%
Mirae Asset Global Investments Co. Ltd. — 0.06%
Los Angeles Capital Management LLC — 0.05%
Allspring Global Investments Holdings LLC — 0.05%
Sumitomo Mitsui Trust Holdings Inc. — 0.04%
Learn More about top institutional investors of Ironwood Pharmaceuticals stock.
Which institutional investors are selling Ironwood Pharmaceuticals stock?: During the previous quarter, IRWD stock was sold by these institutional investors:
Yousif Capital Management LLC
Prairiewood Capital LLC
Intrinsic Value Partners LLC
Grimes & Company Inc.
In the previous year, company insiders that have sold Ironwood Pharmaceuticals company stock include:
Thomas A Mccourt (CEO)
Mark G Currie (Director)
Jason Rickard (COO)
Michael Shetzline (CMO)
Learn More investors selling Ironwood Pharmaceuticals stock.
Which institutional investors are buying Ironwood Pharmaceuticals stock?: In the last quarter, IRWD stock was purchased by institutional investors including:
Hodges Capital Management Inc.
Los Angeles Capital Management LLC
Sumitomo Mitsui Trust Holdings Inc.
Daiwa Securities Group Inc.
Allspring Global Investments Holdings LLC
New York State Teachers Retirement System
China Universal Asset Management Co. Ltd.
Simplex Trading LLC
Within the last year, these company insiders have bought Ironwood Pharmaceuticals stock:
Thomas A Mccourt (CEO)
Mark G Currie (Director)
Learn More investors buying Ironwood Pharmaceuticals stock.

AI finds its first serious application

From Wall Street Star | Ad